Comparing the effectiveness of combination therapy and monotherapy on quality of life in patients with persistent allergic rhinitis
Phase 2
- Conditions
- allergic rhinitis.Vasomotor and allergic rhinitis
- Registration Number
- IRCT20200909048677N1
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Patients with allergic rhinitis who are symptomatic for more than 4 weeks and also more than 4 days a week
Existence of persistent allergic rhinitis during the last 2 years
Age 18-65 years
Exclusion Criteria
unwillingness to cooperate
Severe upper respiratory tract disease during the 6 weeks prior to the study
Nasal polyps or deviation of the nasal septum
Acute or chronic rhinosinusitis
smoking
Bronchial asthma
Pregnancy or breastfeeding
Taking antihistamines during the last 1 month
Use of systemic or topical corticosteroids
History of allergies to Montelukast or Des Loratadine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life score. Timepoint: Once before starting treatment and once 6 weeks after starting treatment. Method of measurement: mini-RQLQ checklist.
- Secondary Outcome Measures
Name Time Method